Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a release of the website interface rather than a modification to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-23T22:28:27.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T19:48:35.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    A new revision label v3.5.0 has been added and the previous revision v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-18T21:54:21.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T19:57:19.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the government funding notice along with Revision: v3.4.1 were removed.
    Difference
    0.3%
    Check dated 2026-02-11T11:00:37.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A government funding lapse notice was added to the page. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:30:06.000Z thumbnail image

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.